Meakins-Christie Labs lead 2024 freezer challenge
The Meakins-Christie Laboratories and the RESP Program came in first place in the 2024 International Freezer Challenge.
News
Respiratory Research News from the Meakins-Christie Laboratories and the RESP program of the RI-MUHC. View our latest funding results, faculty and trainee awards, and our research featured in the media.
2024 Department of Medicine Award Winners
Kevin Schwartzman received the McGill University Department of Medicine Mentor of the Year Award for 2024. Congrats!
Smart Technology Brings New Hope to Neonatal Care
The Smart Hospital Project is improving care for newborns in NICUs with innovative wireless technology.
2024 MGH Research Awards
Several RESP Program researchers are among the recipients of the Montreal General Hospital Foundation’s 2024 Research Awards
Adolescent Vaping Linked to Increased Heart Disease Risk in Men
Two new studies by Carolyn Baglole examine how vaping during adolescence affects the lungs and heart.
Trikafta Prolongs the Lives of Cystic Fibrosis Patients
Larry Lands and Elias Matouk take part in a Radia-Canada digital feature about Trikafta, a drug for Cystic Fibrosis
Meakins-Christie Labs Elevate Lab Recycling
The Meakins-Christie Laboratories was the first research group at the RI-MUHC to pilot a new recycling and sustainability project- led by Severine Audusseau
New Chair of the Department of Critical Care Medicine Appointed
Dr. Salman Qureshi has been appointed Chair of the Department of Critical Care Medicine
A Scalable, Cost-Effective Solution for Single-Cell Profiling
Dr. Jun Ding’s team has developed a groundbreaking tool, scSemiProfiler, to make single-cell sequencing more affordable and accessible.
Introducing Peanuts Earlier to Reduce Allergy Risk
Dr. Christine McCusker was part of the research team that discovered introducing peanuts into a child’s diet before the age of three is an effective strategy to reduce the risk of peanut allergy.